Response to "NGS, the New Global Standard?"

Affiliations

• ¹ Division of Hematology-Oncology, Department of Internal Medicine, University of California Irvine School of Medicine, Orange, California. Electronic address: siou@uci.edu.
• ² Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
• ³ Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany; Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.
• ⁴ Oncology Therapeutic Area Unit, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
• ⁵ Global Medical Affairs Oncology, Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts.
• ⁶ Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Ltd., Tokyo, Japan.
• ⁷ Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; Center for Molecular Pathology (CMP), Institute of Pathology Heidelberg (IPH), University Hospital Heidelberg, Heidelberg, Germany.
• ⁸ Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; Department of Internal Oncology of Thoracic Tumors, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.